Army-SPRING Army-Suicide Prevention Research
Launched by UNIVERSITY OF PENNSYLVANIA · Aug 6, 2024
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
The Army-SPRING clinical trial is focused on improving support for Suicide Intervention Officers (SIOs) within the Connecticut Army National Guard. These officers play a crucial role in helping soldiers who may be struggling with thoughts of suicide by providing education, monitoring for signs of crisis, and connecting them with resources. This study aims to understand how better support for SIOs can help reduce the risk of suicide among their fellow soldiers.
To participate in this trial, you need to be serving as an SIO or a chaplain/religious affairs specialist in a Connecticut Army National Guard unit, and you must be willing to provide informed consent. If you join the study, you can expect to engage in discussions and activities aimed at enhancing the support network for SIOs. This research is important because it seeks to find effective ways to help those who are helping others, ultimately aiming to create a safer environment for all soldiers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Serving as an SIO or chaplain/religious affairs specialist for a unit of the CTARNG
- • Willing to provide informed consent.
- Exclusion Criteria:
- • None
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Philadelphia, Pennsylvania, United States
Hartford, Connecticut, United States
Patients applied
Trial Officials
Lily Brown, PhD
Principal Investigator
University of Pennsylvania
Ashley Hagaman, PhD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported